Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track focuses on the latest advancements in drug discovery methodologies and development processes. It aims to explore novel approaches that enhance the efficacy and safety of pharmaceutical products.
This session addresses the complexities of industrial pharmaceutics, including formulation, manufacturing, and quality control. Participants will discuss innovative techniques to overcome common challenges in the production of pharmaceutical products.
This track highlights the importance of pre-clinical studies in the drug development pipeline. It aims to present methodologies that effectively translate laboratory findings into clinical applications.
This session examines the critical role of pharmacovigilance in ensuring drug safety during clinical trials. Discussions will include regulatory requirements and best practices for monitoring adverse drug reactions.
This track focuses on the design and execution of clinical studies, emphasizing statistical methodologies and ethical considerations. It aims to share insights on optimizing study protocols for better outcomes.
This session explores the intricacies of supply chain management within the pharmaceutical industry. Topics will include logistics, inventory control, and strategies for ensuring a consistent supply of quality products.
This track addresses the environmental challenges associated with pharmaceutical waste management. Participants will discuss sustainable practices and regulatory compliance in waste disposal.
This session focuses on the strategic aspects of product management in pharmaceuticals, including lifecycle management and market analysis. It aims to provide insights into effective product positioning and commercialization.
This track emphasizes the importance of post-marketing surveillance in monitoring drug safety and efficacy after market release. Discussions will include methodologies for collecting and analyzing post-marketing data.
This session delves into the principles of Good Manufacturing Practices (GMP) and their application in the pharmaceutical industry. Participants will explore case studies that highlight the impact of GMP on product quality.
This track focuses on the legal and regulatory aspects of patent applications and drug registration processes. It aims to provide insights into navigating the complexities of intellectual property in pharmaceuticals.